Both ASF1B and hsa_miR_129-5p have been demonstrated to contribute to the same cancers, for example, breast cancer [51,52], prostate cancer [53,54] and RCC [50,55], although no interactions have been established. Here, ASF1B is linked to renal cell carcinoma.